Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis (PROOF)

This study has been completed.
Information provided by:
Biogen Identifier:
First received: January 11, 2008
Last updated: January 26, 2010
Last verified: January 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2003
  Estimated Primary Completion Date: No date given